Genzyme Corporation

10-Jul-2011 | News-Press Release

This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Buy Now: Genzyme Corporation

Browse All: Healthcare Market Research

Features and benefits
• Gain insight into Genzyme's strategic outlook across the next 6 years
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Strategic insight into the prospects for Genzyme over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Your key questions answered
• Benchmark Genzyme's performance against key rivals in the prescription pharmaceutical sector
• Assess the impact of the Allston Landing contamination issues to the company's top line sales performance
• Understand the level of sales growth and portfolio diversification Genzyme will offer Sanofi-Aventis, post acquisition

About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter:
Our Facebook Page:

7557 Rambler road,
Tel: +1-888-989-8004 EXT 106

Show HTML Embed Snippet

This release was submitted by a Newsbox user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment